# Drawing First Blood: Biomarkers and TAVR Outcomes

**Authors:** Craig R. Narins

PMC · DOI: 10.1016/j.jacadv.2023.100760 · JACC: Advances · 2023-12-17

## Full-text entities

- **Diseases:** atherosclerotic disease (MESH:D050197), end-stage aortic stenosis (MESH:D007676), valve obstruction (MESH:D006349), myocardial injury (MESH:D009202), cancer (MESH:D009369), cardiac (MESH:D006331), heart failure (MESH:D006333), fibrosis (MESH:D005355), AS (MESH:D001024), inflammation (MESH:D007249), died (MESH:D003643), mitral and/or tricuspid regurgitation (MESH:D014262), calcification (MESH:D002114), aortic valve disease (MESH:D000082862), stenosis (MESH:D003251), rheumatologic disease (MESH:D012216)
- **Chemicals:** lipid (MESH:D008055), calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11198460/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11198460/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC11198460/full.md

---
Source: https://tomesphere.com/paper/PMC11198460